Role of intrathecal morphine for acute postoperative pain management in patients undergoing Kidney transplant surgery
Phase 4
- Conditions
- Health Condition 1: N186- End stage renal diseaseHealth Condition 2: N186- End stage renal disease
- Registration Number
- CTRI/2023/01/049063
- Lead Sponsor
- Mahatma gandhi hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1American Society of Anaesthesiologists (ASA) III patients
2Age group of 20-60 years
3Patient with written valid consent
4Patient undergoing renal transplant surgery.
Exclusion Criteria
1Patient refusal
2History of allergy to study drug
3contraindication to spinal puncture (e.g. bleeding diathesis, neurologic dysfunction, and recent systemic or local infection);
4insufficient comprehension to use the PCA device,
5history of drug abuse.
6Severe cardiovascular disease
7Patient with neurological disorder
8recent use of psychoactive or analgesic medication
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate and compare the effect of intrathecal morphine versus intrathecal normal saline in terms of duration and quality of analgesia and post operative analgesic consumptionTimepoint: baseline,0,1,3,6,12,24,36,48 hours
- Secondary Outcome Measures
Name Time Method Effect of intrathecal morphine on catheter related bladder discomfort <br/ ><br>To observe any procedure and drug related complicationTimepoint: 0,1,3,6,12,24,36,48 hours